FeesSafety
Pluang+

OmniAb achieves self-sustaining cash flow, aiming for break-even net cash use by 2026.

Market News
01 Nov 2026, 05:19 WIB
Seeking Alpha
View Source
Bullish
OmniAb achieves self-sustaining cash flow, aiming for break-even net cash use by 2026.

OmniAb has reached a point where it no longer needs investor funding to operate, achieving self-sustaining cash flow. The company’s portfolio includes contractually protected options on hundreds of programs, with potential milestones exceeding $3 billion and average royalty rates around 3.4%. Its partnership with Lilly and a strong late-stage pipeline provide validation and upcoming catalysts, including up to 19 clinical trial readouts through 2027. Traditional valuation methods undervalue OmniAb, as its discounted royalty and milestone model better reflects its status as a self-funding platform with moderate asset premium.

OmniAb stock is the subject, with this data providing context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 01, 2026 09:01 WIB: Out of 150 priced US health stocks, 40 rose and 108 fell. Regeneron Pharmaceuticals Inc (REGN) gained 13.33% with a typical hold time of 108 days and a Pluang order activity of 100% sell, contrasting with 10X Genomics Inc (TXG) which dropped 14.03% and Twist Bioscience Corp (TWST) down 11.92%, the latter having a notably shorter typical hold time of 27 days.

More News

Li Auto delivers 29,025 vehicles in October, launches new Li MEGA and Li i6 with advanced tech upgrades

Li Auto delivers 29,025 vehicles in October, launches new Li MEGA and Li i6 with advanced tech upgrades

Li Auto delivered 29,025 vehicles in October 2026, bringing total deliveries to over 1.86 million. The company introduced over 3,000 units of the new Li MEGA and launched the 2026 Li i6 model equipped with its proprietary Lianshan Battery and advance...

Market News
Bullish
33 minutes ago
Binance ETH futures show $11.41M buy bid, with sell orders exceeding buys by $4.94M.

Binance ETH futures show $11.41M buy bid, with sell orders exceeding buys by $4.94M.

A recent snapshot of Binance's Ether (ETH) perpetual futures order book revealed a significant buy bid of 5,039.67 ETH at $2,265, totaling about $11.41 million. The bid price was slightly below the midpoint price of $2,269.01. Overall, buy orders on ...

Market News
Neutral
4 hours ago
Ether rises 1.16% to $2,269, outpacing Bitcoin's 0.52% gain to $77,704

Ether rises 1.16% to $2,269, outpacing Bitcoin's 0.52% gain to $77,704

Ether (ETH) increased by 1.16% over 24 hours, reaching $2,269.34, outperforming Bitcoin (BTC), which rose 0.52% to $77,704 as of late October 31. This price movement highlights Ether's stronger short-term momentum compared to Bitcoin during this peri...

Market News
Bullish
4 hours ago
Direxion Semiconductor Bull 3X ETF upgraded to buy, expecting AI chip stocks rally by year-end.

Direxion Semiconductor Bull 3X ETF upgraded to buy, expecting AI chip stocks rally by year-end.

Mike Zaccardi upgrades Direxion Daily Semiconductor Bull 3X ETF (SOXL) to buy, anticipating a rally in AI semiconductor stocks by year-end. SOXL is highly volatile and best for short-term trades due to negative compounding risks. Technical analysis s...

Analyst Insights
Bullish
4 hours ago
Super Pepe token surges 83% in 24 hours, leading crypto search interest on Oct 31

Super Pepe token surges 83% in 24 hours, leading crypto search interest on Oct 31

Super Pepe (SP) token saw a significant 83.04% price increase in the past 24 hours, trading at $0.0178 with a market cap of about $17.8 million, topping the crypto search list on Oct 31. Other notable cryptocurrencies included Solana (SOL), which tra...

Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App